Health Care & Life Sciences » Pharmaceuticals | Dong Wha Pharm Co. Ltd.

Dong Wha Pharm Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
31,184
35,643
51,076
66,750
129,611
103,667
Total Accounts Receivable
54,736
56,216
57,570
57,827
66,864
79,450
Inventories
30,437
28,382
26,151
26,577
36,606
43,718
Other Current Assets
403
307
217
337
1,419
1,053
Total Current Assets
116,760
120,548
135,015
151,492
234,500
227,887
Net Property, Plant & Equipment
171,902
161,854
151,777
142,171
103,746
96,772
Total Investments and Advances
14,472
17,939
16,689
20,344
20,841
35,383
Intangible Assets
8,265
7,108
6,432
6,442
6,137
5,581
Other Assets
648
-
-
1,056
1,117
1,117
Total Assets
316,166
313,073
317,187
324,605
367,225
370,599
ST Debt & Current Portion LT Debt
4,000
4,000
2,000
-
-
Accounts Payable
18,496
17,980
17,170
25,672
21,776
Income Tax Payable
4,210
635
1,003
3,840
13,874
Other Current Liabilities
46,667
46,300
48,977
25,940
25,066
Total Current Liabilities
73,373
68,915
69,149
55,452
60,717
Long-Term Debt
2,000
-
-
-
-
Provision for Risks & Charges
13,369
14,347
17,839
15,978
9,324
Deferred Taxes
4,118
5,625
7,274
3,100
884
Other Liabilities
192
85
81
249
239
Total Liabilities
88,934
83,347
87,069
71,679
70,280
Common Equity (Total)
227,231
229,726
230,118
252,925
296,945
Total Shareholders' Equity
227,231
229,726
230,118
252,925
296,945
Total Equity
227,231
229,726
230,118
252,925
296,945
Liabilities & Shareholders' Equity
316,166
313,073
317,187
324,605
367,225

About Dong Wha Pharm Co.

View Profile
Address
19th Floor, STX Namsan Tower
Seoul SL 04637
Korea, Republic Of
Employees -
Website http://www.dong-wha.co.kr
Updated 07/08/2019
Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digesting, skin scars, general cold, gum treatment, high blood pressure, infection, controlling gastrointestinal tract, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.